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MicroRNAs play important roles in post-transcriptional regulation of gene expression by inhibiting protein translation and/or 
promoting mRNA degradation. Importantly, biogenesis of microRNAs displays specific temporal and spatial profiles in dis-
tinct cell and tissue types and hence affects a broad spectrum of biological functions in normal cell growth and tumor devel-
opment. Recent discoveries have revealed sophisticated mechanisms that control microRNA production and homeostasis in 
response to developmental and extracellular signals. Moreover, a link between dysregulation of microRNAs and human brain 
disorders has become increasingly evident. In this review, we focus on recent advances in understanding the regulation of mi-
croRNA biogenesis and function in neuronal and glial development in the mammalian brain, and dysregulation of the mi-
croRNA pathway in neurodevelopmental and neurodegenerative diseases. 
microRNAs, neuronal development, synaptic plasticity, oligodendroglial differentiation, brain tumor, neurodegenera-
tive disorders 
 





1  Molecular mechanisms that control biogene-
sis of microRNAs 
MicroRNAs are short 18–25 nucleotide small non-coding 
RNA molecules that function to silence gene expression via 
sophisticated post-transcriptional regulation [1]. In mam-
mals, the primary precursors of microRNAs (pri-micro- 
RNAs) are transcribed by RNA polymerase II (for details of 
microRNA biogenesis, see recent reviews [2,3]) and 
cleaved by the nuclear RNase III endonuclease, Drosha, 
along with its regulatory subunit DGCR8. As a result, char-
acteristic 70–100 nucleotide stem-loop precursor mi-
croRNAs are generated (pre-microRNAs) in the nucleus, 
sometimes even derived from introns after RNA splicing 
[46]. Pre-microRNAs are exported to the cytoplasm by 
Exportin5 and further processed by the RNase III, Dicer, to 
produce mature microRNAs of short duplexes from the ter-
minal loop. Besides this canonical pathway for microRNA 
biogenesis, emerging evidence indicates the existence of 
atypical mechanisms for transcription and processing of 
virally encoded pri-microRNAs that are closely related to 
transfer RNA (tRNA) biogenesis [7], which in turn con-
verge on the DICER-dependent pathway to generate mature 
viral microRNAs. Whether cellular orthologues for compo-
nents in this atypical pathway exist or this is a viral-specific 
mechanism remains unknown. Moreover, the biogenesis 
and stability of specific microRNAs can be modulated by 
selective RNA-binding proteins (RBPs) that are not core 
components of the microRNA machinery. In particular, 
numerous RBPs were recently found to modulate mi-
croRNA processing. For example, RBP LIN28 suppresses 
the biogenesis of let-7 microRNA by binding to the terminal 
loop of pri-let-7, thereby blocking Drosha cleavage [8]. In-
terestingly, in cells lacking LIN28, the KH-type splicing 
regulatory protein (KHSRP, also known as KSRP) recog-
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nizes the terminal loop of let-7 and promotes its maturation 
by facilitating its association with Drosha in the nucleus or 
with Dicer in the cytoplasm [9]. In contrast, another canon-
ical splicing regulator, heteronuclear ribonucleoprotein A1 
(hnRNPA1), binds to the same sequence in the pri-let-7 
terminal loop to repress Drosha-mediated processing [9]. In 
fact, many RBPs classically known for regulating pre- 
mRNA splicing are now found to play crucial roles in mod-
ulating microRNA biogenesis. 
The mature microRNA duplexes are incorporated into 
the RNA-induced silencing complex (RISC) consisting of 
Dicer, TRBP, and Ago proteins, in which one or both 
strands of a microRNA are presented to cognate binding 
sites, also called microRNA recognition elements (MREs), 
in the protein-coding mRNA(s) to form an RNA hybrid via 
imperfect complementary base pairing. MREs are often 
located in the 3′ untranslated regions (UTRs) of the target 
mRNAs [10], although clear examples also demonstrate the 
capability for microRNAs to target the open reading frame 
of the target mRNA [1113]. A single microRNA has the 
potential to target hundreds of distinct mRNA molecules to 
suppress expression of the encoded protein. On the other 
hand, multiple microRNAs are predicted to act on the same 
mRNA and most likely synergistically function to suppress 
expression of the target. Overall, more than 50% of human 
mRNAs are predicted to be targets of microRNAs [14]. 
Multiple molecular mechanisms have been reported that 
underlie microRNA-mediated gene silencing, including 
block of cap-dependent translation initiation, shortening of 
the polyA tail length, and degradation of the target mRNAs 
[15]. Besides targeting mRNAs, the most recent discoveries 
have revealed a new model for microRNA function, in 
which specific microRNAs, represented by miR-709 and 
miR-107, can directly target microRNA biogenesis post- 
transcriptionally [16,17], demonstrating a functional hier-
archy within the microRNA pathway. Moreover, RBPs play 
a role in activation or relief of microRNA repression. For 
example, HuR, an AU-rich element-binding protein, re-
lieves the miR-122-mediated repression of CAT-1 mRNA 
by interfering with microRNA binding to the 3′-UTR of 
target mRNAs [18]. In contrast, repression of c-Myc mRNA 
by the let-7 microRNA is enhanced by the HuR binding to 
adjacent AREs [19]. This suggests that regulation of mi-
croRNA-mediated repression by RBPs is probably a wide-
spread phenomenon. 
Despite the ubiquitous presence and essential roles of the 
microRNA pathway in all cell types examined [20], expres-
sion of microRNAs in response to external signals is highly 
dynamic at both spatial and temporal levels, which is an 
apparently important mechanism that governs cell growth 
and development [1]. Interestingly, microRNAs are partic-
ularly abundant in the brain. At least 60% of known mi-
croRNA species are detected in the adult brain [21] and 
many are drastically regulated during embryonic brain de-
velopment [22]. Upon neural lineage specification, a sub-
class of microRNAs, represented by miR-9, miR-124, and 
miR-128, are specifically expressed in neurons and play 
pivotal roles in neuronal development and synaptic plastici-
ty. In contrast, distinct microRNA species are preferentially 
expressed in glial lineages, which control normal glia cell 
proliferation and differentiation [2325]. Specifically, 
miR-219 and miR-338 are crucial for the development of 
oligodendroglia, the cell type responsible for myelination of 
neuronal axons to enable proper conductivity in the brain 
[23]. Besides cell type-specificity, particular microRNAs 
demonstrate unique patterns of regional and subcellular 
localization in the brain. For example, miR-218, miR-221, 
miR-222, miR-26a, miR-128a/b, miR-138, and let-7c are 
preferentially enriched in the hippocampus, while miR-195, 
miR-497, and miR-30b are found to be enriched in the cer-
ebellum [21]. This regional specificity in microRNA ex-
pression reflects the different cell composition within vari-
ous brain regions. miR-134 and miR-26a are relatively en-
riched in neuronal dendrites in which local protein synthesis 
underlies synaptic plasticity, the foundation for learning and 
memory [26,27]. Consistent with the idea that microRNAs 
may be involved in modulating local protein synthesis, 
miR-200c, miR-339 and miR-332 are present in biochemi-
cal preparations that are enriched in synapses [28]. Exam-
ples of microRNAs in specific cell lineages and subcellular 
compartments are illustrated in Figure 1.  
2  Essential roles of microRNA pathways in dis-
tinct neural cell types  
Because conventional deletion of the Dicer gene arrests 
microRNA processing and results in early embryonic lethal-
ity [29], conditional knockout of Dicer, which is required 
for microRNA biogenesis, has been used extensively to 
examine the collective roles of microRNAs in specific tis-
sues and cell types in mice. Elimination of Dicer in neural 
stem cells causes profound defects in embryonic brain de-
velopment and lethality [30,31]. Apoptosis and failures in 
developing specialized neuronal arborizations are common 
detrimental effects in distinct neuronal populations as a re-
sult of losing DICER function. In specific neuronal cell 
types, the loss of Dicer in mature dopaminergic neurons 
leads to a progressive loss of midbrain dopaminergic neu-
rons and markedly reduced locomotion, which is reminis-
cent of human patients with Parkinson’s disease [32]. Abla-
tion of Dicer function in Purkinje neurons leads to Purkinje 
cell death, followed by cerebellar degeneration and the de-
velopment of ataxia [33]. Moreover, conditionally inactivate 
Dicer in forebrain and hippocampal neurons results in 
changes in dendrite morphology, spine length, apoptosis, 
microcephaly, ataxia, and lethality by 3 weeks after birth 
[34]. The importance of microRNA biogenesis is further 
supported by the fact that haploinsufficiency of the mi-
croRNA processer, Dgcr8, also leads to altered plasticity 
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Figure 1  MicroRNA expression in specific cell lineages. 
and cognitive dysfunction [3537].  
Besides brain neurons, functional requirements of mi-
croRNA pathways are also demonstrated by conditional 
knockout of Dicer in specialized neural cells in the retina, 
cochlea, and olfactory bulb. In addition, loss of Dicer in 
distinct glial cell populations also severely affects the de-
velopment and function of the nervous system, because of 
the crucial roles of glia in supporting and modulating neu-
ronal function [38]. Specifically, Dicer deficiency in the 
oligodendroglia lineage and Schwann cells causes failures 
in myelination of the central and peripheral nervous system 
(CNS and PNS) respectively [24,25,3941]. Interestingly, 
mice that loose Dicer in astrocytic glia do not show severe 
defects until the age of five weeks, characterized by pro-
gressive ataxia, cerebellar degeneration and seizures, con-
sistent with the critical role of astroglia in neurotransmitter 
abundance and modulation of synaptic function [42]. All 
these observations clearly demonstrated the profound global 
function of microRNA pathways in the nervous system. The 
functional impairment of the nervous system by conditional 
elimination of microRNA biogenesis in various neural cell 
types is summarized in Table 1. 
3  Specific microRNAs in neuronal development 
and synaptic plasticity 
Several specific microRNAs have been found to have im-
portant effects on neuronal development via regulation of 
mRNA targets. For example, neuron-specific miR-124 
promotes neuronal differentiation by directly targeting PTB, 
which encodes a global repressor for alternative pre-mRNA 
splicing in non-neuronal cells [43]. The miR124-dependent 
silencing of PTB in neural stem cells is an important mech-
anism that permits neuronal lineage establishment and neu-
ronal differentiation. Antagonizing miR-124 results in sus-
tained PTB expression and suppresses neuronal-specific 
alternative splicing, and severely attenuates neuronal dif-
ferentiation [43]. In addition, miR-9* and miR-124 inhibit 
neural progenitor cell specific BAF53a and BAF45a respec-
tively, reducing proliferation and inducing differentiation 
[44]. Moreover, expression of miR-9/9* and miR-124 
(miR-9/9*-124) in human fibroblasts is sufficient to induce 
their conversion into neurons [45]. These studies indicate 
that neuronal-specific microRNAs have instructive roles in 
neural fate determination. 
In addition to neural lineage development, proper synap-
tic strength and connectivity are a crucial prerequisite for 
the function of the brain. In mature neurons that are con-
nected in sophisticated synaptic circuitry, a number of ma-
ture microRNA species are found in the dendrites and syn-
apses where active protein synthesis occurs locally to gov-
ern synaptic plasticity and cognitive ability [28,46], sug-
gesting a function of microRNAs in synaptic mRNA trans-
lation. Two profiling studies have identified dendritic-  
enriched microRNAs by either laser capture microdissection 
of dendrites isolated from primary rat hippocampal neurons 
[27] or biochemical isolation of synaptosomes, a biological 
fraction enriched for synaptic terminals [47]. The presence 
of functional components of the microRNA pathway in-
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Table 1  Functional impairment by conditional elimination of microRNA biogenesis 
Specific cell types Specific Cre Phenotypes Ref 
Purkinje cells Pcp2-Cre-Dicer1 Cell death, cerebellar degeneration, ataxia [33] 
Dopaminergic neurons DAT-Cre-Dicer1 Cell loss, reduced locomotion [32] 
Dopaminoceptive neurons DR-1-Cre-Dicer1 Ataxia, front and hind limb clasping, reduced brain size, and 
smaller neurons but not cell death 
[48] 
Spinal motor neurons VAChT-Cre-Dicer1 Sclerosis, aberrant end plate architecture, myofiber atrophy, 
and spinal muscular atrophy 
[49] 
Neural stem and progenitor 
cells in cortex 
Emx1-Cre-Dicer1 Apoptosis, impairs neuronal differentiation, thinner cortical 
wall and death before P30 
[30,31,50] 
Neural stem and progenitor 
cells in brain 
Nestin-Cre-Dicer1 Thinner cortical wall (E18.5), reduced number of late-born 
neurons and abnormal migration; very few embryos, no sur-
viving newborns 
[31] 
Neurons of cortex and hip-
pocampus 
CaMKII-Cre-Dicer Dendritic branch elaboration reduces, dendritic spine length 
increases, increased cortical apoptosis, smaller cortex, mi-




Adult forebrain neurons CaMK-CreERT2-Dicer1 
 
Tamoxifen begins 810 weeks, a cumulative neuronal cells 
loss after 14 weeks of tamoxifen, improved learning and 
memory, increases posttetanic potentiation, elongated filo-
podia-like shaped dendritic spines 
[52] 
Retina Chx10-Cre-Dicer1 Retina cells disorganization and degeneration, morphological 
defects, ERG responses decreases, inability to respond to 
light 
[53] 
Retinal progenitor cells Pax6-Cre-Dicer1 Increases early-born cell types, fail to generate late-born cells [54] 
Retinal progenitor cells DKK3-Cre-Dicer1 Massive death of retinal progenitor cells, abnormal cell dif-
ferentiation 
[55] 
Inner ear hair cells Pou4f3-Cre-Dicer1 Deaf, with no response to auditory stimuli [56] 
Olfactory progenitor cells Foxg1-Cre-Dicer1 Die in utero, have small eyes and forebrains, and develop 
small snouts 
[57] 
Mature olfactory neurons OMP-Cre-Dicer1 Viable, show normal olfactory-related functions [57] 
OPCs and Oligodendrocytes Olig2-Cre-Dicer1 Demyelinating phenotypes begin P10, but disappear at P60 [24] 
OPCs and Oligodendrocytes Olig1-Cre-Dicer1 Demyelinating phenotype (severe tremor, ataxia, unmyelin-
ated axons), die week 3 
[25] 
OPCs and Oligodendrocytes Oligo1-Cre-Dicer1 Oligodendrogenesis suppressed, astrogliogenesis is absent, 
die immediately after birth. 
[58] 
OPCs CNP-Cre-Dicer1 Demyelinating (P9-10, develop notable tremor), peripheral 
neuropathy, die week 4 
[24] 
OPCs CNP-Cre-Dicer1 Oligodendrocytes reduces, die before adulthood [59] 
Mature oligodendrocytes PLP-CreERT-Dicer1 CNS impairment (ataxia, paralysis, kyphosis, and early 
death); progressively severe hind limb ataxia until paralysis 
and kyphosis 
[39] 
Schwann cells Dhh-Cre-Dicer1 Arrest at immature stages, demyelinating (discoordination, 
tremor, and ataxia), aggravated as older 
[40] 
Schwann cells P0::Cre-Dicer1 Arrest at immature stages, demyelinating (clenching and 
hindlimb), aggravated as older 
[41] 
Astrocytes mGFAP-Cre-Dicer1 Normal before week 5, then progressive ataxia, cerebellar 
degeneration, seizures, uncontrollable movements, and 
premature death by postnatal week 910 
[42] 
All tissues Dgcr8+/ Homozygous mice die before birth, heterozygous reduce ex-




dendrites, including Dicer and Argonaute, as well as 
pre-microRNAs, further implicate the regulation of mi-
croRNA biogenesis [46], in response to neuronal activity 
changes.  
Indeed, neuronal activity has a profound impact on all 
aspects of microRNA biogenesis and function. At the tran-
scriptional level, membrane depolarization or application of 
the neurotrophin, BDNF, activate transcription of miR-132 
by the well-known activity-regulated transcription factor 
CREB [60], while, neuronal activity activates miR-134 
transcription by the transcription factor MEF2 [26]. In con-
trast, the dendritically enriched miR-138 is specifically ex-
pressed in brain neurons, while its precursor pre-miR-138 is 
ubiquitously expressed, suggesting specific post-transcrip- 
tional processing of miR-138 in neurons [61], although 
neuronal specific transacting factors that enable processing 
of pre-miR-138 are yet to be identified. Furthermore, 
emerging evidence has revealed rapid regulation of numer-
ous microRNAs upon neuronal activation under specific 
neurotransmitter receptor-mediated synaptic signaling, most 
likely via regulating the abundance of the microRNA pro-
cessing machinery [46]. Besides microRNA abundance, it is 
important to point out that an expanding number of reports 
demonstrate interplay between microRNAs and RBPs that 
act on the same mRNA targets to modulate microRNA ac-
tivity [62]. The well characterized RBP, HuR, is translocat-
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ed to the cytoplasm upon stress, which relieves cationic 
amino acid transporter 1 (CAT1) mRNA from miR-122- 
mediated repression [18]. In addition, phosphorylation of 
the fragile X mental retardation protein, FMRP, was re-
cently shown to promote the formation of an AGO2-miR- 
125a inhibitory complex on PSD-95 mRNA, which is re-
versed upon mGluR-triggered dephosphorylation of FMRP 
[63]. 
It is clearly demonstrated that activity-regulated mi-
croRNAs can control neuronal development and function. 
In a well characterized example, miR-132 induces for-
mation of dendritic spines and increases the occurrence of 
miniature EPSCs by repressing expression of p250GAP, a 
GTPase activating protein that regulates the Rac1/PAK1 
pathway [64]. In addition, miR-134 regulates dendrite 
growth by targeting RNA-binding protein, Pumilio2 [26], 
and decreases dendritic spine size by repressing LIMK1, a 
kinase that promotes actin polymerization [65]. In contrast, 
miR-138 induces spine shrinkage by targeting depal-
mitoylation enzyme, APT1, and by activation of the 
RhoA-ROCK pathway [47]. 
4  MicroRNAs in oligodendroglial differentia-
tion and myelin formation 
Oligodendroglia in the CNS produce multilamellar myelin 
sheaths wrapping around neuronal axons, which are essen-
tial for axonal protection and saltatory conduction of action 
potentials. Oligodendroglia progenitor cells are specified 
from neural stem/progenitor cells, which proliferate and 
differentiate, and ultimately migrate to interact with axons 
where they become mature oligodendrocytes to form myelin 
sheaths. Abnormal formation and/or maintenance of myelin 
sheaths impairs nerve conduction and leads to progressive 
axonal degeneration, which contributes to the etiology of 
several neurological disorders, including multiple sclerosis 
and schizophrenia. A rich and fast growing literature has 
demonstrated that many intrinsic and extrinsic regulators 
control myelinating cell differentiation in a spatiotemporally 
specific manner. MicroRNAs, as novel post-transcriptional 
regulators, act cooperatively with developmental signals to 
control oligodendrocyte differentiation and myelin for-
mation. In vivo elimination of Dicer1, specifically in oli-
godendroglia, by Olig1, Olig2, or CNP promoter-directed 
expression of the Cre-recombinase causes severe dysmye-
lination and motor behavior deficits, characterized by trem-
ors, ataxia and paralysis [24,25,58,59], demonstrating es-
sential roles of microRNA pathways in oligodendroglia- 
dependent CNS myelination. In fact, OL-specific Dicer 
mutants suffer from oxidative damage, inflammatory astro-
cytosis and microgliosis in the brain, which eventually leads 
to neuronal degeneration and shorter lifespans [39]. Recent 
microarray profiling studies identified specific microRNAs 
that are rigorously regulated during oligodendroglial differ-
entiation [66], supporting the idea that developmentally 
programmed microRNA expression governs oligoden-
droglial lineage development. Interestingly, the neuronal 
specific miR-9 is down-regulated during the transition from 
oligodendroglial progenitor cells that still maintain a certain 
plural potency to mature oligodendrocytes [23]. This sug-
gests that miR-9 may play opposing roles in neuronal and 
glial lineage specification. Regarding functional microRNA 
species in oligodendroglia, several studies collectively 
demonstrate that miR-219 is a major microRNA necessary 
and sufficient to promote oligodendrocyte terminal matura-
tion [24,25]. miR-138 and miR-338 also belong to the same 
class that advances oligodendrocyte differentiation [25]. 
Mechanistically, these aforementioned microRNAs directly 
target and silence transcription factors that suppress oli-
godendroglial differentiation, including ZFP238, FoxJ3, 
Sox3, and Hes5 [24,25], as well as PDGF receptor alpha, 
which mediates PDGF signaling to maintain oligoden-
droglial progenitors [67]. Later on in mature oligodendro-
cytes, miR-219 is believed to target the elongation of very 
long chain fatty acids protein 7 (ELOVL7) to maintain li-
pids and redox homeostasis, which are necessary for sup-
porting axonal integrity as well as for the formation of 
compact myelin. Considering the pivotal role of miR-138 in 
controlling neuronal dendritic spine morphogenesis [47], 
whether miR-138 acts through shared mRNA targets in 
neurons and oligodendroglia or alternatively targets distinct 
downstream pathways, perhaps with the help of neuronal 
and/or glial specific factors, still remains elusive. 
5  MicroRNAs in brain tumor development 
Primary brain tumors, though relatively rare, are the cause 
of a disproportionate level of morbidity and mortality and 
have been the subject of increasingly intensive research 
over the past two decades. Glioma, the most common pri-
mary tumor of the adult CNS, develops from fundamental 
genetic alterations that cause the formation of a tumor stem 
cell population that divides without restriction to normal 
physiological biochemical signaling. Gliomas are classified 
based on the different glial cells types present, including 
ependymomas (ependymal cells), astrocytomas (astrocytes), 
oligodendrogliomas (oligodendrocytes) and glioblastoma 
multiforme (GBM), the most frequent and malignant pri-
mary brain tumor [68]. In contrast, medulloblastoma (MB) 
is the most common brain malignancy in children that arises 
from altered development of cerebellar progenitor cells [69]. 
MicroRNAs certainly play critical roles in cancer initiation, 
progression, and some of them could be considered as clin-
ical biomarkers for cancer diagnosis, prognosis and predic-
tion of therapeutic response [70]. Specifically, expression 
profiling studies have revealed extensive alteration of mi-
croRNAs in primary glioblastoma, suggesting that mi-
croRNAs may represent a new class of genes involved in 
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Table 2  MicroRNAs function as oncomicroRNAs or anti-oncomicroRNAs in glioma and medulloblastoma biology 
MicroRNAs Targets Expression Cellular role Ref 
OncomiRs     
miR-21 PDCD4   [71] 
 HNRPK and TAp63   [72] 
 RECK and TIMP3 Upregulated in GBM Promotes glioma invasion [73] 
 LRRFIP1 Upregulated in GBM Contributes to VM-26 resistance [74] 
 Spry2 Upregulated in glioma Triggers malignancy [75] 
  Upregulated in MB  [76] 
miR-221/222 PUMA Upregulated in GBM Inhibits cell apoptosis [77] 
 PTPμ Upregulated in GBM cell line Increases cell migration and growth [78] 
 p27(Kip1) Upregulated in GBM Increases cell proliferation [79,80] 
 BIRC1 Upregulated in GBM Inhibits cell apoptosis [81] 
miR-17-92 CTGF Upregulated in GBM spheroid  [82] 
  Upregulated in MB  [83,84] 
miR-10b HOXD10 Upregulated in GBM Induces glioma cell invasion [85,86] 
 Bim/AP-2γ/p21/p16 Upregulated in glioma Contributes to glioma growth [87] 
miR-26a PTEN, RB1, and MAP3K2 Upregulated in GBM Facilitates gliomagenesis [88,89] 
Anti-oncomicroRNAs     
miR-34a MAGE-A Downregulated in MB Confers chemosensitivity [90] 
 SIRT1 Downregulated in  
p53-mutantglioma cell line U251 
Inhibits cell growth, migration and invasion, 
induces apoptosis 
[91] 
 c-Met, Notch-1/2 Downregulated in glioma/ GBM Inhibits cell proliferation, survival, migration and 
invasion 
[92,93] 
miR-106a E2F1 Downregulated in glioma Suppresses proliferation and induces apoptosis [94] 
miR-124 SLC16A1 
CDK6  
Downregulated in MB Inhibited cell proliferation [95,96] 






Downregulated in GBM Inhibited cell proliferation [71,98,99] 
 Bmi-1 Downregulated in MB Inhibited cell proliferation, promotes cellular 
senescence 
[100] 
miR-125b Bmf Downregulated in glioma Inhibited cell proliferation [101,102] 
miR-199b-5p HES1 Downregulated in MB Inhibited cell proliferation [103] 
 
oncogenesis [104]. The dysregulated microRNAs in GBM 
could be characterized as oncomiRs or anti-oncomiRs 
through post-transcriptionally regulating oncogenes or an-
ti-oncogenes, respectively (Table 2). In GBM, the dysregu-
lation is characterized by the strong up-regulation of 
miR-221, accompanied by a much broader spectrum of 
down-regulated miRs, including miR-128, miR-181a, 
miR-181b, and miR-181c [104]. Interestingly, dysregulation 
of microRNAs in MBs is characterized by a somewhat 
overlapping microRNA population [105], especially the 
predominant down-regulation of a class of neural mi-
croRNAs, suggesting a tumor growth-inhibitory function of 
these microRNAs. It is worth pointing out that besides 
serving as a biomarker for tumor development, some mi-
croRNAs appear to be drug targets. For example, in glioma, 
knockdown of miR-21 increased apoptotic activity, and 
sensitized cells to cytotoxic tumor therapy [106109]. In 
medulloblastoma, suppression of miR-21 impedes cell mi-
gration [76]. These pioneer studies support alternative 
promising strategies to treat brain tumors. 
6  MicroRNAs in neurodevelopmental and 
neurodegenerative disorders 
A rapidly growing literature has demonstrated that altered 
neuronal plasticity and morphology, as seen in neurodevel-
opmental disorders, may result from disruption of a com-
mon post-translational process that is under tight control by 
microRNAs [110]. Several intellectual disability syndromes, 
such as Fragile X syndrome, Rett syndrome, and Down’s 
syndrome, have been linked to the microRNA pathway 
[110]. Fragile X syndrome, characterized by intellectual 
disability and autistic features, is caused by loss of function 
of the fragile X mental retardation protein (FMRP). FMRP 
is involved in the microRNA pathway through interaction 
with Dicer and Ago1 [111] and association with specific 
microRNAs [112]. Specifically, miR-125b and miR-132  
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have been shown to associate with FMRP in the mouse 
brain and they exert opposing effects on dendritic spine 
morphology and synaptic plasticity. Loss of FMRP amelio-
rates the microRNAs effects on spine morphology [112]. In 
addition, FMRP indirectly regulates miR-124 levels by in-
teraction with the Dicer1-Ago1-complex in Drosophila 
[113], suggesting FMRP may maintain proper levels of 
many microRNAs in neuronal development.  
Rett syndrome is an X-linked neuro-developmental dis-
order caused by mutations in the transcriptional co-rep- 
ressor methyl CpG-binding protein (MeCP2). Upregulation 
or downregulation of MeCP2 both lead to Rett-like syn-
drome in mouse, suggesting maintenance of MeCP2 levels 
in a narrow range is essential for normal brain development 
and function [114]. miR-132, a brain-enriched microRNA, 
has been shown to inhibit MeCP2 translation [115]. More 
interestingly, loss of MeCP2 leads to down-regulation of 
miR-132 by indirect mechanisms [115]. This negative 
feedback loop provides a mechanism for tight homeostatic 
control of MeCP2 expression [115]. Moreover, alterations 
in microRNA profiles in MeCP2-knockout mouse models 
reveal that up-regulated microRNAs are responsible for the 
decreases of BDNF and Irak1 [116,117], which are crucial 
players for normal brain development.  
Parkinson’s disease (PD) is characterized by the progres-
sive neurodegeneration of dopaminergic neurons (DNs) in 
the substantia nigra, leading to tremors, rigidity, and brady-
kinesia [118]. Conditional knockout of Dicer in dopaminer-
gic neurons results in Parkinson’s disease-like phenotypes 
with or without cell loss [32,43], suggesting microRNAs 
regulate homeostatic states in dopaminergic neurons. Con-
sistent with this view, miR-133b is significantly down-  
regulated in midbrain tissue from patients with Parkinson's 
disease [32]. Further studies revealed that miR-133b regu-
lates the maturation and function of midbrain DNs within a 
negative feedback circuit that includes the paired-like 
homeodomain transcription factor, Pitx3 [32]. In addition, 
miR-7 reduces alpha-synuclein protein, the major compo-
nent of Lewy bodies in sporadic PD, through binding the 
3'-UTR of alpha-synuclein mRNA and protecting cells 
against oxidative stress [119,120]. Furthermore, the reduc-
tion of miR-7 in the MPTP-induced PD model further sup-
ports the role of miR-7 in controlling alpha-synuclein levels 
[119], which is critical for the neurodegenerative process in 
PD. 
Finally, emerging evidence also reveals the involvement 
of microRNA malfunction in Alzheimer’s disease (AD), a 
progressive neurological degenerative disorder caused by 
the accumulation of plaques formed of short -amyloid (A) 
peptides. These peptides arise from the proteolytic cleavage 
of the -amyloid precursor protein (APP), by a -secretase 
known as the -site APP-cleaving enzyme (BACE), and 
-secretase. BACE1, a rate-limiting step enzyme for A 
peptide production, is thought to be an important risk factor 
for sporadic AD. Importantly, a number of microRNAs ex-
hibit abnormal expression levels in postmortem AD brain 
tissues compared to matched normal controls [121], and 
many of the altered microRNAs in AD have been shown to 
regulate BACE1 [122124]. Moreover, APP levels are also 
known to be under the regulation of microRNAs [125128]. 
7  Concluding remarks and perspectives 
The pivotal importance of microRNAs in normal develop-
ment and function of the brain has been clearly demon-
strated. The most recent discoveries begin to elucidate an 
integrated picture regarding the function of specific mi-
croRNA species in distinct neural cell lineages, in response 
to different stimulation cues, as well as with respect to 
dysregulated microRNAs in various neurological diseases 
and brain tumors. The changes of microRNA expression 
patterns can serve as informative biomarkers that indicate 
the functional status of a normal brain, as well as disease 
progression and prognosis in brain tumors, neurodevelop-
mental disorders, and neurodegenerative diseases. Given the 
crucial function of microRNAs in governing normal brain 
function and the marked dysregulation of microRNAs in 
brain diseases, the question of whether microRNA function 
can be manipulated to obtain therapeutic benefits is an in-
triguing possibility currently under rigorous investigation. 
To achieve this goal, understanding the molecular mecha-
nisms that regulate microRNA biogenesis and activity, at 
epigenetic, transcriptional and post-transcriptional levels, 
especially by co-operation with selective RBPs in response 
to developmental and synaptic signals, is an important ques-
tion that needs to be delineated by future studies. In addition, 
given the large number of mRNAs predicted to be regulated 
by microRNAs, a practical strategy that fully integrates 
identification and validation of microRNA target sites and 
biological changes of functional mRNA targets by the bio-
logical and disease signatures of microRNAs is urgently 
needed; this is apparently the next challenge. Manipulation 
of one microRNA might simultaneously restore the level of 
a large network of disease-related target genes, which seems 
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